Fraxiparine 5700IU Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Nadroparin (5700IU)
Overview Fraxiparine 5700IU Injection
Nadroparin 5700 IU injection is an antithrombotic medication preventing and treating dangerous blood clots. It inhibits existing clot growth and formation of new clots in vital areas like the legs, lungs, brain, and heart. Administration is by a healthcare professional. Dosage and treatment duration depend on your health status, response to treatment, and specific condition, potentially including age and weight. Continued injections are crucial, even without symptoms, for ongoing protection against clot formation. Discontinuing treatment increases clot risk. Common adverse effects may include bleeding, injection site reactions, elevated liver enzymes, and injection site bruising. Minimize activities increasing bleeding risk, exercising caution with sharp objects during treatment. Inform your physician of high blood pressure, diabetes, or recent stroke history before use. This medication is contraindicated with active bleeding. Disclose all other medications to your doctor to ensure compatibility. Pregnant or breastfeeding individuals should consult their physician before using this injection.
Primary Ingredients of Fraxiparine 5700IU Injection
The provided text is "undefined," offering no content to rephrase.
Uses of Fraxiparine 5700IU Injection
Preventing and managing blood clot formation.
Major Benefits of Fraxiparine 5700IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Fraxiparine 5700IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Fraxiparine 5700IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Fraxiparine 5700IU Injection works:
Clexane 5700 IU injection is a medication that inhibits blood clot development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fraxiparine 5700IU Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Fraxiparine 5700 IU Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Fraxiparine 5700IU Injection while breastfeeding is potentially hazardous. Available human data indicates possible transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability following Fraxiparine 5700IU Injection administration is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Nadroparin calcium 5700 IU injection requires careful administration in individuals with advanced renal impairment. Dosage modification of Nadroparin calcium 5700 IU injection may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Fraxiparine 5700IU Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Fraxiparine 5700IU Injection :
Should you forget a Fraxiparine 5700IU Injection, seek your physician's advice.
Facts to Know About Fraxiparine 5700IU Injection
| Label | Value |
|---|---|
| Chemical Type | Low-molecular-weight heparin |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently